Schedule 13G ownership disclosure

Cytokinetics Inc

COMMON STOCK · CUSIP: 23282W605

Event date: 2025-09-30

Filing-level shares
5,617,334.00
Percent of class
4.7%
  • STATE STREET CORPORATION

    Shares: 5,617,334.00 · Class: 4.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-25-000596
Form type
SCHEDULE 13G
Filer
CYTOKINETICS INC
CIK
CIK 1061983
Filed
Nov 10, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub